Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials in progress
385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results